1 completed, 1 recruiting, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow AeRang Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1) | Phase 1 / Phase 2 | Recruiting | AeRang Kim | 45 | 2026-06-01 | 2026-07-27 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors | Phase 1 | Terminated | AeRang Kim | 2 | 2016-10-01 | 2023-08-29 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors Magnetic Resonance High Intensity Focused Ultrasound - Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors | Phase 1 | Completed | AeRang Kim | 7 | 2014-04-01 | 2025-01-01 |
Carcinoma, Hepatocellular (2) · Neoplasms, Germ Cell and Embryonal (2) · Neuroblastoma (2) · Osteosarcoma (2) · Rhabdomyosarcoma (2) · Sarcoma, Ewing (2) · Wilms Tumor (2) · Desmoid Tumors (1) · Neoplasms (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Neurofibromatosis 1 (1) · Neurofibrosarcoma (1) · Sarcoma (1)
AZD 6244 (1)
United States (3)